About This Special Issue
Pharmacogenomics is the study of the role of genetics in drug disposition and response. Pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Such approaches promise the advent of "personalized medicine"; in which drugs and drug combinations are optimized for each individual's unique genetic makeup. It’s the future model of life science and health care. Reviews and reports by the researchers are involved in this rapidly developing area. This issue focuses on those aspects:
1. The emergence of new pharmacogenomic initiatives and their impact on R&D and regulatory strategies
2. Emerging technologies for accessing and exploiting genomic information
3. Reviews of genotyping and clinical data in particular therapeutic areas
4. Development of novel diagnostic products and strategies
